PEAK6 Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

PEAK6 Group’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-32,700	Closed	-$1.41M	–	5806
2015 Q3	$1.41M	Buy	32,700 +19,300	+144%	+$814K	0.01%	1870
2015 Q2	$566K	Sell	13,400 -4,000	-23%	-$169K	﹤0.01%	2622
2015 Q1	$675K	Buy	17,400 +8,900	+105%	+$343K	0.01%	2273
2014 Q4	$286K	Sell	8,500 -19,600	-70%	-$692K	﹤0.01%	3078
2014 Q3	$984K	Buy	28,100 +500	+2%	+$17.1K	0.01%	1840
2014 Q2	$907K	Buy	27,600 +10,100	+58%	+$346K	0.01%	1724
2014 Q1	$645K	Buy	17,500 +10,700	+157%	+$393K	0.01%	2300
2013 Q4	$261K	Buy	+6,800	New	+$215K	﹤0.01%	3289

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

PEAK6 Group's WX Position: Q4 2015 in Review

PEAK6 Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 95,900 shares — an estimated $4.14M sold.

PEAK6 Group first reported a position in WX in Q1 2014 and held it in 5 quarters. The position peaked at $4.14M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

PEAK6 Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
PEAK6 Group sold 95,900 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $4.14M.
PEAK6 Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 5 quarters.
PEAK6 Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4.14M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on PEAK6 Group's 13F filing for Q4 2015, filed 16 Feb 2016.